• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Classification of antituberculosis drugs: a new proposal based on the most recent evidence.

作者信息

Caminero Jose A, Scardigli Anna

机构信息

Pneumology Department, University Hospital of Gran Canaria "Dr. Negrin", Las Palmas, Spain MDR-TB Unit, International Union against Tuberculosis and Lung Disease (The Union), Paris, France

MDR-TB Unit, International Union against Tuberculosis and Lung Disease (The Union), Paris, France.

出版信息

Eur Respir J. 2015 Oct;46(4):887-93. doi: 10.1183/13993003.00432-2015.

DOI:10.1183/13993003.00432-2015
PMID:26424519
Abstract
摘要

相似文献

1
Classification of antituberculosis drugs: a new proposal based on the most recent evidence.抗结核药物分类：基于最新证据的新提议。
Eur Respir J. 2015 Oct;46(4):887-93. doi: 10.1183/13993003.00432-2015.
2
Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.关于管理耐多药和广泛耐药结核病病例的标准化治疗方案的提案。
Eur Respir J. 2017 Jul 5;50(1). doi: 10.1183/13993003.00648-2017. Print 2017 Jul.
3
World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied?世界卫生组织耐多药结核病治疗推荐：是否应采用不同标准？
Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1211-1213. doi: 10.5588/ijtld.17.0199.
4
Tuberculosis treatment and drug regimens.结核病治疗与药物治疗方案。
Cold Spring Harb Perspect Med. 2015 Jan 8;5(5):a017822. doi: 10.1101/cshperspect.a017822.
5
Easier cure for resistant TB.耐药结核病的更简易治疗方法。
Science. 2017 Feb 17;355(6326):677. doi: 10.1126/science.355.6326.677.
6
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.耐多药肺结核的治疗。
N Engl J Med. 2020 Mar 5;382(10):893-902. doi: 10.1056/NEJMoa1901814.
7
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen.含贝达喹啉治疗方案治疗耐多药和广泛耐药结核病的高治疗成功率。
Eur Respir J. 2018 Dec 20;52(6). doi: 10.1183/13993003.01528-2018. Print 2018 Dec.
8
Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?近期耐多药和广泛耐药结核病相关争议：世卫组织较短耐多药结核病方案和贝达喹啉在全球的实施情况——所有耐多药结核病患者都适用吗？
Respirology. 2018 Jan;23(1):36-45. doi: 10.1111/resp.13143. Epub 2017 Aug 29.
9
Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia.使用贝达喹啉-地拉马尼治疗耐多药结核病的安全性和有效性：来自法国和拉脱维亚的病例系列
Eur Respir J. 2018 Mar 22;51(3). doi: 10.1183/13993003.02550-2017. Print 2018 Mar.
10
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.贝达喹啉和德拉马尼联合治疗 5 例广泛耐药肺结核患者。
Emerg Infect Dis. 2017 Oct;23(10):1718-21. doi: 10.3201/eid2310.170834. Epub 2017 Oct 17.

引用本文的文献

1
Identification and characterization of a novel chromosomal aminoglycoside 3'--phosphotransferase, APH(3')-Id, from DW18 isolated from the sewage of an animal farm.从一个动物养殖场污水中分离出的菌株DW18中鉴定并表征一种新型染色体氨基糖苷3'-磷酸转移酶APH(3')-Id。
Front Microbiol. 2023 Aug 28;14:1224464. doi: 10.3389/fmicb.2023.1224464. eCollection 2023.
2
A pro-oxidant property of vitamin C to overcome the burden of latent infection: A cross-talk review with Fenton reaction.维生素 C 的促氧化剂特性可克服潜伏性感染的负担：与芬顿反应的交叉对话综述。
Front Cell Infect Microbiol. 2023 Apr 19;13:1152269. doi: 10.3389/fcimb.2023.1152269. eCollection 2023.
3
Explicit molecular dynamics simulation studies to discover novel natural compound analogues as inhibitors.
开展显式分子动力学模拟研究以发现新型天然化合物类似物作为抑制剂。
Heliyon. 2023 Jan 30;9(2):e13324. doi: 10.1016/j.heliyon.2023.e13324. eCollection 2023 Feb.
4
Tools to Alleviate the Drug Resistance in .缓解 . 耐药性的工具
Molecules. 2022 Oct 17;27(20):6985. doi: 10.3390/molecules27206985.
5
Pyridine-N-Oxide Alkaloids from and Their Synthetic Disulfide Analogs as Potential Drug Candidates against : A Molecular Docking, QSBAR, and ADMET Prediction Approach.和及其合成二硫化物类似物中的吡啶-N-氧化物生物碱作为抗 的潜在药物候选物：一种基于分子对接、QSAR 和 ADMET 预测的方法。
Biomed Res Int. 2022 Oct 7;2022:6261528. doi: 10.1155/2022/6261528. eCollection 2022.
6
Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?儿童结核病管理：全球挑战还是突破？
Children (Basel). 2022 Jul 27;9(8):1120. doi: 10.3390/children9081120.
7
Are the Newer Carbapenems of Any Value against Tuberculosis.新型碳青霉烯类药物对结核病有任何价值吗？
Antibiotics (Basel). 2022 Aug 7;11(8):1070. doi: 10.3390/antibiotics11081070.
8
Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.结核病和非结核分枝杆菌感染——流行病学、诊断和治疗的比较分析。
J Biomed Sci. 2020 Jun 17;27(1):74. doi: 10.1186/s12929-020-00667-6.
9
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens.《endTB 观察性研究方案：贝达喹啉或含德拉马尼方案治疗耐多药结核病》。
BMC Infect Dis. 2019 Aug 20;19(1):733. doi: 10.1186/s12879-019-4378-4.
10
Linezolid for drug-resistant pulmonary tuberculosis.利奈唑胺用于耐药性肺结核
Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD012836. doi: 10.1002/14651858.CD012836.pub2.